TuisBIO • NYSE
add
Bio-Rad Laboratories, Inc. Class A Common Stock
Vorige sluiting
$242,32
Dagwisseling
$237,97 - $244,24
Jaarwisseling
$215,38 - $387,99
Markkapitalisasie
6,80 mjd USD
Gemiddelde volume
400,77 k
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
NYSE
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (USD) | Des. 2024info | J/J-verandering |
|---|---|---|
Inkomste | 667,48 m | -2,00% |
Bedryfskoste | 283,98 m | 4,64% |
Netto inkomste | -715,80 m | -304,67% |
Netto winsgrens | -107,24 | -308,84% |
Wins per aandeel | 2,90 | -6,45% |
EBITDA | 97,13 m | -26,48% |
Effektiewe belastingkoers | 21,25% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (USD) | Des. 2024info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 1,66 mjd | 3,57% |
Totale bates | 9,36 mjd | -23,86% |
Totale aanspreeklikheid | 2,79 mjd | -21,45% |
Totale ekwiteit | 6,57 mjd | — |
Uitstaande aandele | 28,01 m | — |
Prys om te bespreek | 1,03 | — |
Opbrengs op bates | 1,45% | — |
Opbrengs op kapitaal | 1,72% | — |
Kontantvloei
Netto kontantverandering
| (USD) | Des. 2024info | J/J-verandering |
|---|---|---|
Netto inkomste | -715,80 m | -304,67% |
Kontant van bedrywe | 124,20 m | 53,33% |
Kontant van beleggings | -30,54 m | -142,31% |
Kontant van finansiering | -26,25 m | 86,91% |
Netto kontantverandering | 77,58 m | 244,01% |
Beskikbare kontantvloei | 79,70 m | 391,44% |
Meer oor
Bio-Rad Laboratories, Inc. is an American developer and manufacturer of specialized technological products for the life science research and clinical diagnostics markets. The company was founded in 1952 in Berkeley, California, by husband and wife team David and Alice Schwartz, both graduates of the University of California, Berkeley. Bio-Rad is based in Hercules, California, and has operations worldwide. Wikipedia
Gestig
1952
Webwerf
Werknemers
7 700
